| Name | Dallegro's Pharmacy |
|---|---|
| Organization Name | Jemmison Holding Corp |
| Location | 252 Walnut St, Newark, New Jersey 07105 |
| Type | Pharmacy |
| Phone | (201) 344-8663 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A research team led by UC San Francisco scientists has identified a molecular switch capable of converting unhealthy white fat into healthy, energy-burning brown fat in mice. Drugs that flip this switch rapidly reduced obesity and diabetes risk factors in mice fed a high fat diet.
The New York Times on Sunday examined how Democrats - who for years "have been trying to stop the proliferation of doctor-owned hospitals in the belief that they drive up costs by encouraging doctors to order more procedures" - have moved to "impose new restrictions on these for-profit hospitals" as part of a Senate supplemental war appropriations bill, although they have "carved out exemptions for a few institutions represented by influential senators and well-connected lobbyists."
A major new review of scientific knowledge on kava - a plant used to make dietary supplements and a trendy drink with calming effects - has left unsolved the mystery of why Pacific Island people can consume it safely, while people in the United States, Europe, and other Western cultures sometimes experience toxic effects. The article appears in ACS' journal Chemical Research in Toxicology.
CSC's Leading Edge Forum today released a report that identifies a new wave of disruptive technologies that will reshape the delivery of healthcare. These new technologies will help control costs while improving health by ushering in an era of wellness, self-monitoring, increased and earlier detection of disease, and more effective treatments.
Harbour BioMed, a global clinical stage biopharmaceutical company and Viva Biotech (Shanghai) Ltd., a world-leading structure-based drug discovery platform today announced a strategic partnership under which both parties will collate their respective expertise in drug discovery and development to promote the incubation of innovative biotech startups.
› Verified 3 days ago
| NPI Number | 1629150412 |
| Organization Name | JEMMISON HOLDING CORP |
| Doing Business As | D ALLEGROS PHARMACY |
| Type | Pharmacy |
| Address | 252 Walnut St, Newark, NJ 07105 |
| Phone Number | 973-344-8663 |
News Archive
A research team led by UC San Francisco scientists has identified a molecular switch capable of converting unhealthy white fat into healthy, energy-burning brown fat in mice. Drugs that flip this switch rapidly reduced obesity and diabetes risk factors in mice fed a high fat diet.
The New York Times on Sunday examined how Democrats - who for years "have been trying to stop the proliferation of doctor-owned hospitals in the belief that they drive up costs by encouraging doctors to order more procedures" - have moved to "impose new restrictions on these for-profit hospitals" as part of a Senate supplemental war appropriations bill, although they have "carved out exemptions for a few institutions represented by influential senators and well-connected lobbyists."
A major new review of scientific knowledge on kava - a plant used to make dietary supplements and a trendy drink with calming effects - has left unsolved the mystery of why Pacific Island people can consume it safely, while people in the United States, Europe, and other Western cultures sometimes experience toxic effects. The article appears in ACS' journal Chemical Research in Toxicology.
CSC's Leading Edge Forum today released a report that identifies a new wave of disruptive technologies that will reshape the delivery of healthcare. These new technologies will help control costs while improving health by ushering in an era of wellness, self-monitoring, increased and earlier detection of disease, and more effective treatments.
Harbour BioMed, a global clinical stage biopharmaceutical company and Viva Biotech (Shanghai) Ltd., a world-leading structure-based drug discovery platform today announced a strategic partnership under which both parties will collate their respective expertise in drug discovery and development to promote the incubation of innovative biotech startups.
› Verified 3 days ago
News Archive
A research team led by UC San Francisco scientists has identified a molecular switch capable of converting unhealthy white fat into healthy, energy-burning brown fat in mice. Drugs that flip this switch rapidly reduced obesity and diabetes risk factors in mice fed a high fat diet.
The New York Times on Sunday examined how Democrats - who for years "have been trying to stop the proliferation of doctor-owned hospitals in the belief that they drive up costs by encouraging doctors to order more procedures" - have moved to "impose new restrictions on these for-profit hospitals" as part of a Senate supplemental war appropriations bill, although they have "carved out exemptions for a few institutions represented by influential senators and well-connected lobbyists."
A major new review of scientific knowledge on kava - a plant used to make dietary supplements and a trendy drink with calming effects - has left unsolved the mystery of why Pacific Island people can consume it safely, while people in the United States, Europe, and other Western cultures sometimes experience toxic effects. The article appears in ACS' journal Chemical Research in Toxicology.
CSC's Leading Edge Forum today released a report that identifies a new wave of disruptive technologies that will reshape the delivery of healthcare. These new technologies will help control costs while improving health by ushering in an era of wellness, self-monitoring, increased and earlier detection of disease, and more effective treatments.
Harbour BioMed, a global clinical stage biopharmaceutical company and Viva Biotech (Shanghai) Ltd., a world-leading structure-based drug discovery platform today announced a strategic partnership under which both parties will collate their respective expertise in drug discovery and development to promote the incubation of innovative biotech startups.
› Verified 3 days ago
Komishanes Pharmacy Type: Pharmacy Location: 199 Stuyvesant Ave, Newark, New Jersey 07106 Phone: (973) 399-0900 | |
Dallegro's Pharmacy Type: Pharmacy Location: 252 Walnut St, Newark, New Jersey 07105 Phone: (201) 344-8663 | |
Rite Aid Pharmacy 10402 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 104 12th Ave, Newark, New Jersey 07107 Phone: (973) 621-0580 | |
Olshins Pharmacy Inc Type: Pharmacy Location: 114 Congress St, Newark, New Jersey 07105 Phone: (973) 344-9000 | |
Cvs Pharmacy #02261 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 275 Chestnut St, Newark, New Jersey 07105 Phone: (793) 274-1901 |